Accurate diagnosis for mild traumatic brain injury (mTBI) remains challenging, as prognosis
and return-to-play/work decisions are based largely on patient reports. Numerous …

S100B is a calcium‐binding peptide produced mainly by astrocytes that exert paracrine and
autocrine effects on neurons and glia. Some knowledge has been acquired from in vitro and …

Background: Biomarker levels in blood after traumatic brain injury (TBI) may offer diagnostic
and prognostic tools in addition to clinical indices. This study aims to validate glial fibrillary …

J. Neurochem.(2012) 120, 644–659. Abstract S100B is a calcium‐binding protein
concentrated in glial cells, although it has also been detected in definite extra‐neural cell …

Objective: To study the ability of glial (glial fibrillary acidic protein [GFAP] and S100b) and
neuronal (neuron specific enolase [NSE]) protein levels in peripheral blood to predict …

STUDY OBJECTIVE: Emergency physicians often use the Glasgow Coma Scale (GCS) to
help guide decisions in patient care, yet the reliability of the GCS has never been tested in a …

Ninety percent of patients with minor head injury (MHI) who have cranial computed
tomography (CCT) under the present clinical decision rules have normal scans. Serum …

Abstract S100B protein (S100B) has been described as a marker of brain injury. Various
cytokines also increase in the cerebrospinal fluid (CSF) of patients with severe traumatic …

Traumatic brain injury is a major health and socioeconomic problem that affects all societies.
However, traditional approaches to the classification of clinical severity are the subject of …

STUDY OBJECTIVE: A computed tomography (CT) scan has high sensitivity in detecting
intracranial injury in patients with minor head injury but is costly, exposes patients to high …